NASDAQ$JAGX
Jaguar Health Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
JAGX Q1 2024 — $2.3M revenue, 31.00 EPS
The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties. Jaguar Health Inc reported Q1 2024 results. Diluted EPS came in at $31.00. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $2.3M.
- Diluted EPS: $31.00.
- Filed on Form 10-Q (accession 0001558370-24-008050).
Headline financials
Revenue & EPS history
Jaguar Health · Revenue · Quarterly
$2.35M
Revenue by segment
Jaguar Health · $20.3M total across 2 segments · Q1 2026
- Human Health$19.9M—98.3%
- Animal Health$345K—1.7%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2024
-6.2%
Avg return
Earnings day
-10.0%
Avg return
5 days after
-12.3%
Avg return
30 days after
24%
11 / 45 earnings
Positive
+23.1%
Q3 2023
Best reaction
-36.4%
Q3 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | -2.4% | -9.6% | — | |
| Q1 2026 | -5.0% | -13.6% | -37.9% | |
| Q3 2025 | +2.9% | -32.0% | -33.1% | |
| Q2 2025 | -17.9% | -25.9% | -24.3% | |
| Q1 2025 | +4.8% | -22.5% | -36.5% | |
| Q4 2024 | +8.8% | -12.6% | +144.8% | |
| Q3 2024 | -4.6% | -10.2% | -11.1% | |
| Q2 2024 | -10.8% | +5.8% | -7.5% | |
| Q1 2024 | -12.2% | -10.7% | -78.7% | |
| Q4 2023 | -17.8% | -6.7% | +150.0% | |
| Q3 2023 | +23.1% | +31.3% | -46.1% | |
| Q2 2023 | -10.8% | -12.6% | -44.9% | |
| Q1 2023 | -31.7% | -32.2% | -28.6% | |
| Q4 2022 | -31.0% | -44.4% | -51.3% | |
| Q3 2022 | -6.7% | -13.3% | -25.3% | |
| Q2 2022 | -8.8% | -8.6% | -32.6% | |
| Q1 2022 | -7.1% | -1.4% | -15.5% | |
| Q4 2021 | -7.4% | +12.8% | +42.5% | |
| Q3 2021 | -16.7% | -20.7% | -35.1% | |
| Q2 2021 | -12.8% | -15.0% | -34.8% | |
| Q1 2021 | -2.4% | +4.7% | +37.8% | |
| Q4 2020 | +13.8% | +14.4% | -13.2% | |
| Q3 2020 | -5.9% | +2.0% | +108.4% | |
| Q2 2020 | -21.3% | -15.3% | -36.5% | |
| Q1 2020 | -1.4% | -0.4% | -1.4% | |
| Q4 2019 | -5.9% | -6.5% | +2.0% | |
| Q3 2019 | -36.4% | -37.9% | -45.0% | |
| Q2 2019 | -23.9% | -27.7% | -16.4% | |
| Q1 2019 | +0.6% | +4.1% | -60.4% | |
| Q4 2018 | -9.8% | -23.9% | -38.6% | |
| Q3 2018 | -4.3% | -8.5% | -33.2% | |
| Q2 2018 | -12.4% | -19.9% | -50.3% | |
| Q1 2018 | -4.4% | -5.7% | -26.6% | |
| Q4 2017 | +4.6% | -1.1% | -9.3% | |
| Q3 2017 | -2.4% | -5.0% | -32.2% | |
| Q2 2017 | -6.3% | -15.4% | -19.7% | |
| Q1 2017 | -1.2% | -0.4% | -16.4% | |
| Q4 2016 | -1.1% | +10.3% | +16.1% | |
| Q3 2016 | -1.9% | -18.8% | -15.8% | |
| Q2 2016 | +3.4% | -6.1% | -23.1% | |
| Q1 2016 | +0.6% | — | — | |
| Q4 2015 | +5.6% | — | — | |
| Q3 2015 | +8.0% | — | — | |
| Q2 2015 | -1.7% | — | — | |
| Q1 2015 | -7.4% | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro